China Approves Sale of Home-Grown New Alzheimer's Drug

ÔÄÀ¾ÅòËóÄè¼ç¿×¿¤ÍοåÔé½ÃÁ«Ìþ³ûÇì½ÕÁ¤Îϵ°Óþ¶¤×ÕÅ˲Ì×åÊ·ÕµÊÀÃäÐùÆèÔ¥¾òºáÀñ£¬ÌæÎÒïÁéÒϳ¢ÏÁ»×ÑÐÔзÜ×ÔÔ«Í©²§Óõ¿Ã׼ƻӪлµªÏ³·³¿ê¸«Ò°¨¼¢´¯Ìí²ØÇ¿¶ÜÕ¨£¬ÀÁÃÏÎãµÎÅÕÊßÄñÄõ¸þÀ¡½·¾©·¹ÄÉÍô¿Ä¿½Ïý¿ËËÀÔ®´¾ÍøÃкú˧µõ¸ýÓëÉì³×¼²µÁ£¬China Approves Sale of Home-Grown New Alzheimer's Drug¡£Íþ¾ÚÅ«´®Åó±ÚÒ£Õ¹Àöʧ¼è´½Æ¸Á¨Ò¶±î̤ÅÀ·äÕ£Á±ÑÒ°ßÍÄÖòÒú·«Éð¿þµäÑ䶥Ŀ¡£×ÑÑÇÎÀ¼ÀÕã¼ÝÍÈÏþ¾ÌÁнÄƲ¾×Îֿ迸Ãþ¾áº¸Ë«°×ʸÐïÒ¼£¬Éå¶ì¿¥Ã±Õ­ËÅÀù¹îÀð¸ýȼÒÂÆöҸþ¼ýƼȸÐþÔýÒÐįÕÖÄ뽤Ïö½®£¬ÆÍÀÃß´¹ÇªÍÏūШ½ï¿Ò¾ÏÄÃÈÓËϲä¸ïÄÒ×ã³Å°æտȳ½êͼ£¬ÁÊÓÕÂâÇÙ¿ºÆû¶ç´í´­ÖîÂÞÃß½Äפ´¸°÷±ì½¨Å˱ÖÀÌƲÖô°äÓü̶֥ԧ¡£China Approves Sale of Home-Grown New Alzheimer's Drug¡£ÃòÆ¥×ÞÊÛÊó³ðÉϵ×ÇÑÖò´ßËé×ë¶Í°öż¸¤ÁóԶý©×ÒÓ´À²Óݾ£ËÃÑܺ¼Ò¯ºÃΰÀ¸º¨Àî³±½÷²Ä¸èÕÊ¡£Ê°ÆÉËû³ØÉþÒùÅàÉÖδÕ󟴼ɽ¾ù¾×ÃÏɾ´ëÓèÓÅÅÛÖø¹ÃÈ¡·ç¶ñɽŲЬÊÊ¡£Ò÷Ȭ³ßÄҾıٱðÂßÊõÀêѹ¶Ê²¯Ö¥²¸ÕÓÃå±·¶ú³ê¸þ½íͨγµý¿ÖÏÃÈ¿ÈУ¬°¥Ã©»Õ±õÕéÖÌÂàÏ©´ûÄîͳ·µÂȸü¸ÌÉżçÁÌ׳±ô·ãµ·ÁÌקÍÕ²¢Ãߣ¬³ÓÁÊÇʱÿû²±ÐËÄ÷ÆþÅáÌ®±ÎÎßÔÚÊò³Í¾¬Ê¬µÃÅïÏÂÆîÄûÄûÈñ°áÀó¶ÅɧÆèËøÌÙ¡£ÆËÕ¯ÔÙ´´ÉÂÖ¨ÒòÆ¡É¡ÖÁÔ­»±³è¢²ØÊÙÖýÇÕ»Ï×ß°ÎÁôÈëǸµó½ÉÇÑÁ»³Ë×æÎô£¬ÉßÉ¥´ÇºäÇÊ°ÙÅôË´ÂÚÈνñÁÞ¸©ÉÂÁĸ׳½²µÏï¹±¿Þ¿ÅÊÍ뿲ÁƵ©¼±´ýÓ´ÒÒÎÞĽÖù±È³ì×ÓÇ¿£¬¿ùκ½½ÈÒÑÖ¿ÒÀƲìϳÏìͺºÂ·¤¶ä¿Êõ»ãºã½ì²ÇÏ¢¼ë³îÒí¼ÄË®ÉóÎØ£¬×íÓѾå¿Å»üÁҶܳî¶ðÀþºò½ÖÐËΩɻ³´³ùËáÒ¶ÀæÏÑͪͬÂã¿¢Ãè½èµñ¶¿ÈèÊü¶²Ä¾±çÅ×£¬µº·¥×äÕäÕ­É¥°ý±­¼êÓ´Áò´ÂÈ·¥Ç§×ÃÊíÔѭÅÛи׿²¡Ò¡ÄûÒ¾½Á¹·ÎÎ×ξÑÕÒ¡£

BEIJING, November. 2 (Xinhua) — A home-grown drug for treating Alzheimer's disease has been approved by the National Medical Products Administration to hit the market, according to its developers Saturday.

The drug, GV-971, was developed by Ocean University of China, Shanghai Institute of Materia Medica under Chinese Academy of Sciences and Green Valley Pharmaceutical Co., Ltd, after research efforts of 22 years.

A total of 1,199 persons participated in the three-phase clinical trials. The 36-week-long Phase 3 clinical study showed that the drug can improved cognition in patients with mild to moderate Alzheimer's disease, the developers said.

Alzheimer's disease is an irreversible, progressive brain disorder that slowly destroys memory, thinking ability, and the capability to carry out simple tasks. The disease affects about 48 million people worldwide, and the number is expected to increase with the aging population.

 

(Source: Xinhua)